BKV vs EXE: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: EXE is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BKV and EXE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BKV and EXE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

BKV Corporation produces natural gas from the Barnett Shale in the Fort Worth Basin of Texas and from the Marcellus Shale in northeast Pennsylvania. It is the largest operator in the Barnett by a wide margin, with gross operated volumes of roughly 1,101 MMcfe/d against about 162 MMcfe/d for the next largest producer, sitting on roughly 6 Tcfe of proved reserves with a one-year base decline near 10.7%. Around that upstream base the company has bolted on two other segments. It owns 75% of BKV-BPP Power, which runs the ~1.5 GW Temple I and Temple II combined-cycle plants in ERCOT, after buying half of Banpu Power's interest in January 2026 for ~$115M in cash plus ~5.3 million newly issued shares. It also runs a carbon capture, utilization and sequestration arm whose Barnett Zero project has injected about 375,800 metric tons of CO2 equivalent since 2023, joined in 2026 by the Cotton Cove and Eagle Ford facilities.

Full BKV guide

Expand Energy Corporation (NASDAQ: EXE) is the largest natural gas producer in the US lower 48, created on October 1, 2024 when Chesapeake Energy and Southwestern Energy completed their all-stock merger and rebranded as Expand Energy. The company produces roughly 7.5 billion cubic feet equivalent per day (about 93% natural gas) from premier shale positions in the Appalachian Basin (Marcellus and Utica) and the Haynesville Shale in Louisiana and East Texas. Its strategy centers on low-cost, high-margin gas production, capital discipline, debt reduction, and returning cash to shareholders through a base dividend and buybacks.

Full EXE guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BKV drivers: Barnett scale with a shallow decline curve; Texas power demand and the Temple plants.
• EXE drivers: Scale and low-cost synergies; LNG and structural demand growth.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Natural gas prices drive most of the upstream result, and a realized price near $2.60/Mcf leaves limited cushion if Henry Hub and Waha weaken, with hedges smoothing rather than removing that exposure. For EXE, expand's single biggest risk is natural gas price volatility, since it is a near pure-play producer with limited commodity diversification, so a mild winter, storage oversupply, or associated-gas growth can sharply cut cash flow.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BKV if you believe its drivers more; EXE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BKV and EXE guides.

BKV. The trailing earnings multiple looks undemanding, but it sits on a year that included the gain and accounting effects of taking control of the power joint venture, which is why the forward multiple roughly doubles. Capital spending of ~$690 million to ~$875 million for 2026 runs well ahead of operating cash flow near ~$326 million on a trailing basis, so the balance sheet, not earnings, is doing the funding. Anyone comparing BKV to a pure-play gas producer is comparing different businesses, since roughly a third of the capital budget now goes to power and carbon rather than to drilling.

EXE. EXE's results swing with gas prices: Q1 2026 revenue jumped about 41% year over year to roughly $4.4 billion as realized gas prices rose near $4.92 per Mcf, driving a swing back to profitability. With a market cap around $21 billion and enterprise value near $24 billion, the stock trades as a large-cap gas producer whose valuation multiples compress and expand with the forward gas curve. Trailing twelve-month revenue of roughly $11.6 billion reflects the recent price recovery rather than a stable run-rate.

Headline figures (approximate, August 2026): BKV shows market cap ~$2.7B (share price ~$24, enterprise value ~$3.8B), revenue (ttm) ~$1.5B (lifted by consolidating the Temple power plants from January 2026), net production (q2 2026) ~978 MMcfe/d, above the ~925 to 975 guidance range, adjusted ebitdax (q2 2026) ~$142M, with net income of ~$75.8M (~$0.67 per diluted share); EXE shows revenue (ttm) ~$11.6B, q1 2026 net income ~$1.16B, q1 2026 adj. eps ~$3.83, market cap ~$21B.

BKV and EXE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BKV and EXE exposure against your real portfolio. It is not an investment adviser.